Skip to main content
OpenTrials
Completed

NCT Number: NCT04513236

Use of Airtime Timing to Improve Interactive Voice Response Surveys in Bangladesh and Uganda

This study evaluates the effect of two different airtime incentive timings on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to a control group, in Bangladesh and Uganda.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute of Epidemiology Disease Control and Research, Dhaka, Bangladesh

Loading trial locations.

About this study

Using random digit dialing sampling techniques, the study randomized RDD participants to one of three airtime incentive timings, some of all of that incentive being contingent on their completing the noncommunicable disease risk factor survey. This mobile phone survey was sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; if you are female, press 2). This study was conducted in both Bangladesh and Uganda.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara, or English languages.

Exclusion criteria

  • Less than 18 years of age

Treatment and study plan

Pre-survey incentive

Other

An incentive of is given in the form of airtime to motivate participants to complete the survey. Participants were sent 0.1X before the were sent a mobile phone survey and an additional 1X after completing the survey.

Post-survey incentive

Other

An incentive in the form of airtime to motivate participants to complete the survey. Participants were given Bangladeshi Taka or Ugandan Shillings worth of certain airtime for completing the survey.

Primary outcomes

  1. Cooperation Rate #1

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs.

  2. Response Rate #4

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Secondary outcomes

  1. Refusal Rate #2

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns

  2. Contact Rate #2

    Time frame: Through study completion, an average of one month

    As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

Sponsors and collaborators

Lead sponsor

Johns Hopkins Bloomberg School of Public Health

Other

Collaborators

  • Institute of Epidemiology, Disease Control and Research
  • Makerere University

Registry information

Official study title

A Randomized Controlled Trial of Varying Airtime Incentive Timing to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Uganda

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Aug 14, 2020
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.